Search Results - "Santana‐Rivera, Yasmarie"

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma by Grafals-Ruiz, Nilmary, Rios-Vicil, Christian I, Lozada-Delgado, Eunice L, Quiñones-Díaz, Blanca I, Noriega-Rivera, Ricardo A, Martínez-Zayas, Gabriel, Santana-Rivera, Yasmarie, Santiago-Sánchez, Ginette S, Valiyeva, Fatma, Vivas-Mejía, Pablo E

“…Glioblastoma (GBM) is the most common and lethal of the central nervous system (CNS) malignancies. The initiation, progression, and infiltration ability of…”
Get full text

Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells by Rabelo-Fernández, Robert J, Noriega Rivera, Ricardo A, Rivera, Yasmarie Santana, Tous-Beveraggi, José, Valiyeva, Fatima, Vivas-Mejia, Pablo E

“…RNA-Binding Protein with Multiple Splicing (RBPMS) is a member of family proteins that bind to nascent RNA transcripts and regulate their splicing,…”
Get full text

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma by Grafals-Ruiz, Nilmary, Sánchez-Álvarez, Annelis O, Santana-Rivera, Yasmarie, Lozada-Delgado, Eunice L, Rabelo-Fernandez, Robert J, Rios-Vicil, Christian I, Valiyeva, Fatima, Vivas-Mejia, Pablo E

“…Glioblastoma (GBM) is a highly aggressive and lethal primary brain tumor. Despite limited treatment options, the overall survival of GBM patients has shown…”
Get full text

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells by Rabelo-Fernández, Robert J, Santiago-Sánchez, Ginette S, Sharma, Rohit K, Roche-Lima, Abiel, Carrion, Kelvin Carrasquillo, Rivera, Ricardo A Noriega, Quiñones-Díaz, Blanca I, Rajasekaran, Swetha, Siddiqui, Jalal, Miles, Wayne, Rivera, Yasmarie Santana, Valiyeva, Fatima, Vivas-Mejia, Pablo E

“…Worldwide, the number of cancer-related deaths continues to increase due to the ability of cancer cells to become chemotherapy-resistant and metastasize. For…”
Get full text

Decreased Expression of Enolase‐I Promotes Cisplatin Resistance of Ovarian Cancer Cells by Rabelo‐Fernández, Robert Joe, Vivas‐Mejia, Pablo, Santana‐Rivera, Yasmarie

“…Platinum‐containing anticancer drugs has been used for more than four decades has effective treatment for ovarian cancer and many others solid tumors. However,…”
Get full text

MicroRNA‐92b is a potential therapeutic target for Glioblastoma treatment by Grafals‐Ruiz, Nilmary, Lozada‐Delgado, Eunice, Santana‐Rivera, Yasmarie, Rivera‐Diaz, Monica, Valiyeva, Fatma, Vivas‐Mejía, Pablo

“…Glioblastoma is the most aggressive type of primary brain tumor with an overall survival of 14.6 months with standard care treatment (surgery, radiotherapy,…”
Get full text

Abstract 2538: MiR-92b targets FBXW7 in GBM cells by Sanchez-Alvarez, Annelis Odette, Grafals-Ruiz, Nilmary, Santana-Rivera, Yasmarie, Valiyeva, Fatma, Rosado-Rivera, Nathaly M., Vivas-Mejía, Pablo E.

“…Abstract MicroRNA (miRNA) dysregulation plays a central role in the initiation, progression, and drug resistance of virtually all cancer types. MiRNA-based…”
Get full text

Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression by Lozada-Delgado, Eunice L, Grafals-Ruiz, Nilmary, Miranda-Román, Miguel A, Santana-Rivera, Yasmarie, Valiyeva, Fatma, Rivera-Díaz, Mónica, Marcos-Martínez, María J, Vivas-Mejía, Pablo E

“…Glioblastoma (GBM) is the most common and aggressive of all brain tumors, with a median survival of only 14 months after initial diagnosis. Novel therapeutic…”
Get full text

Erratum: Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells by Santana-Rivera, Yasmarie, Rabelo-Fernández, Robert J, Quiñones-Díaz, Blanca I, Grafals-Ruíz, Nilmary, Santiago-Sánchez, Ginette, Lozada-Delgado, Eunice L, Echevarría-Vargas, Ileabett M, Apiz, Juan, Soto, Daniel, Rosado, Andrea, Meléndez, Loyda, Valiyeva, Fatima, Vivas-Mejía, Pablo E

“…[This corrects the article on p. 1275 in vol. 12, PMID: 32355541.]…”
Get full text

Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells by Santana-Rivera, Yasmarie, Rabelo-Fernández, Robert J, Quiñones-Díaz, Blanca I, Grafals-Ruíz, Nilmary, Santiago-Sánchez, Ginette, Lozada-Delgado, Eunice L, Echevarría-Vargas, Ileabett M, Apiz, Juan, Soto, Daniel, Rosado, Andrea, Meléndez, Loyda, Valiyeva, Fatima, Vivas-Mejía, Pablo E

Get full text

Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells by Santana-Rivera, Yasmarie, Rabelo-Fernández, Robert J, Quiñones-Díaz, Blanca I, Grafals-Ruíz, Nilmary, Santiago-Sánchez, Ginette, Lozada-Delgado, Eunice L, Echevarría-Vargas, Ileabett M, Apiz, Juan, Soto, Daniel, Rosado, Andrea, Meléndez, Loyda, Valiyeva, Fatima, Vivas-Mejía, Pablo E

“…Despite good responses to first-line treatment with platinum-based combination chemotherapy, most ovarian cancer patients will relapse and eventually develop a…”
Get full text